Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medic...
May 14, 2025, 6:00 AM EDT - 2 months ago
May 13, 2025, 4:30 PM EDT - 2 months ago
May 2, 2025, 7:00 AM EDT - 2 months ago
Mar 17, 2025, 4:05 PM EDT - 4 months ago
Mar 13, 2025, 6:19 AM EDT - 4 months ago
Feb 11, 2025, 8:55 AM EST - 5 months ago
Jan 16, 2025, 8:55 AM EST - 6 months ago
Jan 15, 2025, 8:55 AM EST - 6 months ago
Jan 8, 2025, 4:05 PM EST - 6 months ago
Dec 11, 2024, 6:30 PM EST - 7 months ago
Dec 9, 2024, 9:16 PM EST - 7 months ago
Nov 25, 2024, 11:30 AM EST - 8 months ago
Nov 25, 2024, 9:56 AM EST - 8 months ago
Nov 24, 2024, 9:37 AM EST - 8 months ago
Nov 23, 2024, 5:15 PM EST - 8 months ago
Nov 23, 2024, 1:00 PM EST - 8 months ago
Nov 22, 2024, 11:59 AM EST - 8 months ago
Nov 21, 2024, 12:00 PM EST - 8 months ago
Nov 20, 2024, 12:41 PM EST - 8 months ago
Nov 20, 2024, 11:00 AM EST - 8 months ago
Nov 18, 2024, 1:30 PM EST - 8 months ago
Nov 17, 2024, 3:00 PM EST - 8 months ago
Nov 14, 2024, 9:18 PM EST - 8 months ago
Nov 13, 2024, 1:15 PM EST - 8 months ago
Nov 11, 2024, 4:00 PM EST - 8 months ago
Nov 11, 2024, 2:45 PM EST - 8 months ago
Nov 9, 2024, 12:30 PM EST - 8 months ago
Nov 4, 2024, 11:00 AM EST - 9 months ago